165 related articles for article (PubMed ID: 12586773)
1. Opposing roles for the insulin-like growth factor (IGF)-II and mannose 6-phosphate (Man-6-P) binding activities of the IGF-II/Man-6-P receptor in the growth of prostate cancer cells.
Schaffer BS; Lin MF; Byrd JC; Park JH; MacDonald RG
Endocrinology; 2003 Mar; 144(3):955-66. PubMed ID: 12586773
[TBL] [Abstract][Full Text] [Related]
2. Altered ligand binding by insulin-like growth factor II/mannose 6-phosphate receptors bearing missense mutations in human cancers.
Devi GR; De Souza AT; Byrd JC; Jirtle RL; MacDonald RG
Cancer Res; 1999 Sep; 59(17):4314-9. PubMed ID: 10485478
[TBL] [Abstract][Full Text] [Related]
3. Binding of urokinase-type plasminogen activator receptor (uPAR) to the mannose 6-phosphate/insulin-like growth factor II receptor: contrasting interactions of full-length and soluble forms of uPAR.
Kreiling JL; Byrd JC; Deisz RJ; Mizukami IF; Todd RF; MacDonald RG
J Biol Chem; 2003 Jun; 278(23):20628-37. PubMed ID: 12665524
[TBL] [Abstract][Full Text] [Related]
4. Insulin-like growth factors I and II are autocrine factors in stimulating proteoglycan synthesis, a marker of differentiated chondrocytes, acting through their respective receptors on a clonal human chondrosarcoma-derived chondrocyte cell line, HCS-2/8.
Takigawa M; Okawa T; Pan H; Aoki C; Takahashi K; Zue J; Suzuki F; Kinoshita A
Endocrinology; 1997 Oct; 138(10):4390-400. PubMed ID: 9322955
[TBL] [Abstract][Full Text] [Related]
5. Disruption of ligand binding to the insulin-like growth factor II/mannose 6-phosphate receptor by cancer-associated missense mutations.
Byrd JC; Devi GR; de Souza AT; Jirtle RL; MacDonald RG
J Biol Chem; 1999 Aug; 274(34):24408-16. PubMed ID: 10446221
[TBL] [Abstract][Full Text] [Related]
6. Mannose-6-phosphate enhances cross-linking efficiency between insulin-like growth factor-II (IGF-II) and IGF-II/mannose-6-phosphate receptors in membranes.
MacDonald RG
Endocrinology; 1991 Jan; 128(1):413-21. PubMed ID: 1846107
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of insulin-like growth factor II (IGF-II)-dependent cell growth by multidentate pentamannosyl 6-phosphate-based ligands targeting the mannose 6-phosphate/IGF-II receptor.
Zavorka ME; Connelly CM; Grosely R; MacDonald RG
Oncotarget; 2016 Sep; 7(38):62386-62410. PubMed ID: 27694692
[TBL] [Abstract][Full Text] [Related]
8. The chick embryo fibroblast cation-independent mannose 6-phosphate receptor is functional and immunologically related to the mammalian insulin-like growth factor-II (IGF-II)/man 6-P receptor but does not bind IGF-II.
Yang YW; Robbins AR; Nissley SP; Rechler MM
Endocrinology; 1991 Feb; 128(2):1177-89. PubMed ID: 1846580
[TBL] [Abstract][Full Text] [Related]
9. High-affinity ligand binding by wild-type/mutant heteromeric complexes of the mannose 6-phosphate/insulin-like growth factor II receptor.
Hartman MA; Kreiling JL; Byrd JC; MacDonald RG
FEBS J; 2009 Apr; 276(7):1915-29. PubMed ID: 19236480
[TBL] [Abstract][Full Text] [Related]
10. CREG inhibits migration of human vascular smooth muscle cells by mediating IGF-II endocytosis.
Han Y; Cui J; Tao J; Guo L; Guo P; Sun M; Kang J; Zhang X; Yan C; Li S
Exp Cell Res; 2009 Nov; 315(19):3301-11. PubMed ID: 19769965
[TBL] [Abstract][Full Text] [Related]
11. IGF-II/mannose 6-phosphate receptor activation induces metalloproteinase-9 matrix activity and increases plasminogen activator expression in H9c2 cardiomyoblast cells.
Chang MH; Kuo WW; Chen RJ; Lu MC; Tsai FJ; Kuo WH; Chen LY; Wu WJ; Huang CY; Chu CH
J Mol Endocrinol; 2008 Aug; 41(2):65-74. PubMed ID: 18495691
[TBL] [Abstract][Full Text] [Related]
12. Size at birth and cord blood levels of insulin, insulin-like growth factor I (IGF-I), IGF-II, IGF-binding protein-1 (IGFBP-1), IGFBP-3, and the soluble IGF-II/mannose-6-phosphate receptor in term human infants. The ALSPAC Study Team. Avon Longitudinal Study of Pregnancy and Childhood.
Ong K; Kratzsch J; Kiess W; Costello M; Scott C; Dunger D
J Clin Endocrinol Metab; 2000 Nov; 85(11):4266-9. PubMed ID: 11095465
[TBL] [Abstract][Full Text] [Related]
13. Kinetics of insulin-like growth factor II (IGF-II) interaction with domain 11 of the human IGF-II/mannose 6-phosphate receptor: function of CD and AB loop solvent-exposed residues.
Zaccheo OJ; Prince SN; Miller DM; Williams C; Kemp CF; Brown J; Jones EY; Catto LE; Crump MP; Hassan AB
J Mol Biol; 2006 Jun; 359(2):403-21. PubMed ID: 16631789
[TBL] [Abstract][Full Text] [Related]
14. Mannose-6-phosphate/insulin-like growth factor II receptor expression and tumor development.
Hébert E
Biosci Rep; 2006 Feb; 26(1):7-17. PubMed ID: 16779663
[TBL] [Abstract][Full Text] [Related]
15. An insulin-like growth factor II (IGF-II) affinity-enhancing domain localized within extracytoplasmic repeat 13 of the IGF-II/mannose 6-phosphate receptor.
Devi GR; Byrd JC; Slentz DH; MacDonald RG
Mol Endocrinol; 1998 Nov; 12(11):1661-72. PubMed ID: 9817593
[TBL] [Abstract][Full Text] [Related]
16. Secreted CREG inhibits cell proliferation mediated by mannose 6-phosphate/insulin-like growth factor II receptor in NIH3T3 fibroblasts.
Han YL; Guo P; Sun MY; Guo L; Luan B; Kang J; Yan CH; Li SH
Genes Cells; 2008 Sep; 13(9):977-86. PubMed ID: 18691225
[TBL] [Abstract][Full Text] [Related]
17. Decreased expression of the mannose 6-phosphate/insulin-like growth factor-II receptor promotes growth of human breast cancer cells.
Chen Z; Ge Y; Landman N; Kang JX
BMC Cancer; 2002 Jul; 2():18. PubMed ID: 12149131
[TBL] [Abstract][Full Text] [Related]
18. Cellular response to latent TGF-beta1 is facilitated by insulin-like growth factor-II/mannose-6-phosphate receptors on MS-9 cells.
Ghahary A; Tredget EE; Mi L; Yang L
Exp Cell Res; 1999 Aug; 251(1):111-20. PubMed ID: 10438576
[TBL] [Abstract][Full Text] [Related]
19. Mannose 6-phosphate/insulin-like growth factor II receptor mediates the growth-inhibitory effects of retinoids.
Kang JX; Bell J; Beard RL; Chandraratna RA
Cell Growth Differ; 1999 Aug; 10(8):591-600. PubMed ID: 10470859
[TBL] [Abstract][Full Text] [Related]
20. IGF-II/mannose-6-phosphate receptor signaling induced cell hypertrophy and atrial natriuretic peptide/BNP expression via Galphaq interaction and protein kinase C-alpha/CaMKII activation in H9c2 cardiomyoblast cells.
Chu CH; Tzang BS; Chen LM; Kuo CH; Cheng YC; Chen LY; Tsai FJ; Tsai CH; Kuo WW; Huang CY
J Endocrinol; 2008 May; 197(2):381-90. PubMed ID: 18434368
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
